Staar Surgical Co

STAANASDAQ · USD
20.49USD-0.75 (-3.54%)
375

Staar Surgical Co (STAA) Expected Move

STAA expected move through Sep 18, 2026 is 8.7%, with 0 days to expiration. The implied range is $18.64 to $22.34, based on the previous trading day's options prices.

Read more

Tracking the STAA expected move helps you see how far Staar Surgical Co's options market is pricing the stock to travel over a given period — whether that's the next day, week, or earnings cycle. Staar Surgical Co's expected move is derived directly from option premiums and gives you an objective range to plan trades, set strikes, and manage risk. Use our scanner to monitor the STAA expected move for this week's options, in real time.

The expected move is typically calculated from at-the-money straddle prices (or a blend of straddles and strangles) and represents roughly a one-standard-deviation range over the chosen timeframe. For STAA, comparing the implied expected move to actual realized moves over similar windows tells you whether the options market has historically overestimated or underestimated volatility. The STAA expected move for this week's options pricing is especially useful for short-dated traders, earnings players, and anyone selling premium who needs to know where the market thinks Staar Surgical Co is unlikely to go.

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices.

It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Iron condors, weekly premium sales, directional swing trades — they all live or die by where the market thinks the stock won't go. Our scanner tracks the STAA expected move across every expiration, benchmarks it against realized moves, and shows you when implied ranges are out of line with history. The Staar Surgical Co expected move for this week's options is the fastest read on short-term risk, which gives you a quick way to interpret what the options market thinks about STAA.

STAA Price

EARN
EM

Drag chart to pan. Drag axes to zoom.

ExpirationDTEExpected move (USD)Expected move (%)Upper priceLower price
Sep 18, 20260$1.858.7%$22.34$18.64
Oct 16, 202628$3.1114.7%$23.60$17.38
Nov 20, 202663$4.5521.4%$25.04$15.94
Dec 18, 202691$4.9323.2%$25.42$15.56

As of September 17, 2026

Know What the Market Expects From STAA

Track the STAA expected move across every expiration, filter by IV rank and liquidity, and trade around the range the market is already pricing in.

Start your 14-day free trial